The Khmer Boxing Federation (KBF) has appointed Nin Vanda as acting secretary-general, replacing Sien Sopheak, who submitted his resignation on September 19. The appointment was made at AEON Mall 3 on ...

Vanda Pharmaceuticals stands at a pivotal point, leveraging strong Fanapt growth and a robust late-stage pipeline for future expansion. VNDA's aggressive investment in commercial infrastructure has ...

The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...

Overview: Vanda Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes therapies for high unmet medical needs globally, with a market cap of approximately $303.76 million ...

UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma of the US, which is already fending off an overture from Future Pak. The $8-per-share offer values Nasdaq-listed Vanda at ...

Shares of Vanda Pharmaceuticals rose after a study evaluating its treatment to prevent side effects from weight-loss drug Wegovy met its primary endpoint. The stock climbed 18%, to $5.20, late Tuesday ...

The latest price target for Vanda Pharmaceuticals (NASDAQ:VNDA) was reported by HC Wainwright & Co. on November 19, 2025. The analyst firm set a price target for $20.00 expecting VNDA to rise to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Vanda Pharmaceuticals Inc. before investing. In this article, we go over a few ...